UTICA, N.Y.--(BUSINESS WIRE)--Jan. 8, 2019--
CONMED Corporation (NASDAQ:CNMD) today announced that it will
report financial results for the fourth quarter and fiscal year 2018
after the market close on Tuesday, January 22, 2019. The Company’s
management will host a conference call at 4:30 p.m. ET that same day to
discuss the results.
To participate in the conference call, dial 844-889-7792 (domestic) or
661-378-9936 (international) and refer to the passcode 4781517.
This conference call will also be webcast and can be accessed from the
“Investors” section of CONMED's website at www.conmed.com.
The webcast replay of the call will be available at the same site
approximately one hour after the end of the call.
A recording of the call will also be available from 7:30 p.m. ET on
Tuesday, January 22, 2019, until 7:30 p.m. ET on Wednesday, February 6,
2019. To hear this recording, dial 855-859-2056 (domestic) or
404-537-3406 (international) and enter the passcode 4781517.
About CONMED Corporation
CONMED is a medical technology company that provides surgical devices
and equipment for minimally invasive procedures. The Company’s products
are used by surgeons and physicians in a variety of specialties,
including orthopedics, general surgery, gynecology, neurosurgery and
gastroenterology. CONMED has a direct selling presence in 19 countries,
and international sales constitute approximately 50% of the Company’s
total sales. Headquartered in Utica, New York, the Company employs
approximately 3,100 people. For more information, visit www.conmed.com.
Forward-Looking Statements
This press release and the January 22, 2019 conference call may contain
forward-looking statements based on certain assumptions and
contingencies that involve risks and uncertainties, which could cause
actual results, performance, or trends to differ materially from those
expressed in the forward-looking statements herein or in previous
disclosures. For example, in addition to general industry and economic
conditions, factors that could cause actual results to differ materially
from those in the forward-looking statements may include, but are not
limited to, the risk factors discussed in the Company's Annual Report on
Form 10-K for the fiscal year ended December 31, 2017, and listed under
the heading Forward-Looking Statements in the Company’s most
recently filed Form 10-Q. Any and all forward-looking statements are
made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995 and relate to the Company’s performance on
a going-forward basis. The Company believes that all forward-looking
statements made by it have a reasonable basis, but there can be no
assurance that management’s expectations, beliefs or projections as
expressed in the forward-looking statements will actually occur or prove
to be correct.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190108005956/en/
Source: CONMED Corporation
315-624-3317
CONMED Corporation
Todd
W. Garner
Chief Financial Officer
ToddGarner@conmed.com